Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume -, Issue -, Pages 1-8
Publisher
IOS Press
Online
2021-07-28
DOI
10.3233/cbm-201021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes
- (2019) Naofumi Asano et al. Nature Communications
- Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer
- (2019) Mahdieh Farzanehpour et al. Virology Journal
- Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
- (2019) Marc Arbyn et al. Lancet Global Health
- MicroRNAs as markers of progression in cervical cancer: a systematic review
- (2018) Barbara Pardini et al. BMC CANCER
- MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7
- (2017) Yongfeng Cao et al. Oncology Letters
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients
- (2012) M Schrevel et al. BRITISH JOURNAL OF CANCER
- Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis
- (2012) S M Wilting et al. ONCOGENE
- Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer
- (2012) DONG-XIAN PENG et al. ONCOLOGY REPORTS
- Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
- (2012) Michael G. Schrauder et al. PLoS One
- Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix
- (2012) Long Huang et al. PLoS One
- Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein
- (2011) Bao Hua Li et al. EUROPEAN JOURNAL OF CANCER
- Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma
- (2011) Kazuma Ohyashiki et al. PLoS One
- Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
- (2010) Nobuyoshi Kosaka et al. CANCER SCIENCE
- Polo-like kinase 1 (Plk1) in non-melanoma skin cancers
- (2010) Travis Schmit et al. CELL CYCLE
- Targeting Polo-like Kinase in Cancer Therapy
- (2010) Y. Degenhardt et al. CLINICAL CANCER RESEARCH
- Reduced miR-34a Expression in Normal Cervical Tissues and Cervical Lesions With High-Risk Human Papillomavirus Infection
- (2010) Baohua Li et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Identification of Polo-like Kinase 1 as a Potential Therapeutic Target in Anaplastic Thyroid Carcinoma
- (2009) T. C. Nappi et al. CANCER RESEARCH
- Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer
- (2009) Wei Shi et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Polo-like kinase 1 reaches beyond mitosis—cytokinesis, DNA damage response, and development
- (2008) Tohru Takaki et al. CURRENT OPINION IN CELL BIOLOGY
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started